• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对化疗耐药三阴性乳腺癌的新策略。

Novel strategies to target chemoresistant triple-negative breast cancer.

作者信息

Venkatesh Jaganathan, Rishi Arun K, Reddy Kaladhar B

机构信息

John D. Dingell VA Medical Center, Wayne State University, Detroit, MI, USA.

Department of Oncology, Wayne State University, Detroit, MI, USA.

出版信息

Genes Cancer. 2020 Jul 22;11(3-4):95-105. doi: 10.18632/genesandcancer.204. eCollection 2020 Dec 31.

DOI:10.18632/genesandcancer.204
PMID:33488948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7805540/
Abstract

Previous studies from our group and others have shown that current drug treatment(s) strategies eliminate bulk of tumor cells (non-CSCs) but it had a minimal effect on cancer stem cells (CSCs) leading to resistance and tumor recurrence. We studied the effects of CFM-4.16 (CARP-1 functional mimetic) and/or cisplatin on four Triple-negative breast cancer (TNBC) MDA-MB-468, MDA-MB-231, CRL-2335 and BR-1126, two cisplatin resistant CisR/MDA-231 and CisR/MDA-468 and cancer stem cells (CSCs) from resistant cell lines. TNBC cells treated with CFM-4.16 plus cisplatin inhibited the expression of FZD8, LRP6 and c-Myc and significantly enhanced cell death in all the cell lines by ~70%-80% compared with the control(s). When Cisplatin resistant CisR/MDA-231 and CisR/MDA-468 were treated with CFM-4.16 plus cisplatin, they also showed a reduction in FZD8 and LRP6 and increased apoptosis compared to control group. Similarly, CFM-4.16 plus cisplatin treatment reduced mammospheres formation abilities of CSCs by 80-90% compared to control group, increased PARP cleavage and apoptosis. Data shows CFM-4.16 plus cisplatin treatment significantly increased apoptosis/cell death in parental, cisplatin resistant and CSCs. Taken together the data suggests that FZD8-mediated Wnt-signaling plays a major role in mediating CSCs growth and resistance to chemotherapy and its inhibition enhances the chemotherapeutic response in TNBC.

摘要

我们团队及其他团队之前的研究表明,当前的药物治疗策略可消除大部分肿瘤细胞(非癌症干细胞),但对癌症干细胞(CSCs)的影响极小,从而导致耐药性和肿瘤复发。我们研究了CFM-4.16(CARP-1功能模拟物)和/或顺铂对四种三阴性乳腺癌(TNBC)细胞系MDA-MB-468、MDA-MB-231、CRL-2335和BR-1126、两种顺铂耐药细胞系CisR/MDA-231和CisR/MDA-468以及耐药细胞系中的癌症干细胞(CSCs)的影响。与对照组相比,用CFM-4.16加顺铂处理的TNBC细胞抑制了FZD8、LRP6和c-Myc的表达,并在所有细胞系中显著增强细胞死亡,增幅约为70%-80%。当用CFM-4.16加顺铂处理顺铂耐药的CisR/MDA-231和CisR/MDA-468时,与对照组相比,它们的FZD8和LRP6也有所减少,且凋亡增加。同样,与对照组相比,CFM-4.16加顺铂处理使CSCs的乳腺球形成能力降低了80%-90%,增加了PARP裂解和凋亡。数据表明,CFM-4.16加顺铂处理显著增加了亲代细胞、顺铂耐药细胞和CSCs中的凋亡/细胞死亡。综上所述,数据表明FZD8介导的Wnt信号在介导CSCs生长和化疗耐药中起主要作用,对其抑制可增强TNBC的化疗反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/1a236e14d60d/ganc-11-95-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/e902b40fe3c5/ganc-11-95-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/c95ec9d7b9bf/ganc-11-95-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/b5e00c64344e/ganc-11-95-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/383534cb0ce6/ganc-11-95-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/8ab082d7b17a/ganc-11-95-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/1a236e14d60d/ganc-11-95-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/e902b40fe3c5/ganc-11-95-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/c95ec9d7b9bf/ganc-11-95-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/b5e00c64344e/ganc-11-95-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/383534cb0ce6/ganc-11-95-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/8ab082d7b17a/ganc-11-95-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/7805540/1a236e14d60d/ganc-11-95-g006.jpg

相似文献

1
Novel strategies to target chemoresistant triple-negative breast cancer.针对化疗耐药三阴性乳腺癌的新策略。
Genes Cancer. 2020 Jul 22;11(3-4):95-105. doi: 10.18632/genesandcancer.204. eCollection 2020 Dec 31.
2
CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers.CARP-1功能模拟物是耐药性三阴性乳腺癌的新型抑制剂。
Oncotarget. 2016 Nov 8;7(45):73370-73388. doi: 10.18632/oncotarget.12333.
3
Cisplatin and TRAIL enhance breast cancer stem cell death.顺铂和 TRAIL 增强乳腺癌干细胞死亡。
Int J Oncol. 2011 Oct;39(4):891-8. doi: 10.3892/ijo.2011.1085. Epub 2011 Jun 16.
4
Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells.Myc介导三阴性乳腺癌细胞中的癌干细胞样细胞及上皮-间质转化变化。
PLoS One. 2017 Aug 17;12(8):e0183578. doi: 10.1371/journal.pone.0183578. eCollection 2017.
5
Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer.肿瘤起始细胞和 FZD8 在三阴性乳腺癌的耐药性中起主要作用。
Mol Cancer Ther. 2013 Apr;12(4):491-8. doi: 10.1158/1535-7163.MCT-12-1090. Epub 2013 Feb 27.
6
Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.新型CARP-1功能模拟化合物作为非小细胞肺癌和三阴性乳腺癌抑制剂的鉴定与测试
J Biomed Nanotechnol. 2015 Sep;11(9):1608-27. doi: 10.1166/jbn.2015.2099.
7
Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44CD24 Sorted MDA-MB-231 Cells by Cisplatin.顺铂对亲本及CD44CD24分选的MDA-MB-231细胞中细胞及癌症干细胞相关假定基因表达的调控
Pharmaceuticals (Basel). 2021 Apr 21;14(5):391. doi: 10.3390/ph14050391.
8
Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.Stat3/Oct-4/c-Myc 信号通路调控三阴性乳腺癌干细胞多柔比星耐药及 WP1066 的抑制作用
Int J Oncol. 2018 Jul;53(1):339-348. doi: 10.3892/ijo.2018.4399. Epub 2018 May 8.
9
VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.血管内皮生长因子C(VEGF-C)抑制通过上调组织蛋白酶抑制剂maspin逆转膀胱癌细胞对顺铂的耐药性。
Mol Med Rep. 2015 Aug;12(2):3163-9. doi: 10.3892/mmr.2015.3684. Epub 2015 Apr 24.
10
Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells.靶向抑制miR-221/222可增强三阴性乳腺癌MDA-MB-231细胞对顺铂的敏感性。
Front Genet. 2020 Jan 14;10:1278. doi: 10.3389/fgene.2019.01278. eCollection 2019.

引用本文的文献

1
Utility of Multicellular Spheroids for Investigating Mechanisms of Chemoresistance in Triple-Negative Breast Cancer.多细胞球体在研究三阴性乳腺癌化疗耐药机制中的应用
Int J Mol Sci. 2025 Aug 3;26(15):7503. doi: 10.3390/ijms26157503.
2
The splicing factor CCAR1 regulates the Fanconi anemia/BRCA pathway.剪接因子 CCAR1 调控范可尼贫血/BRCA 通路。
Mol Cell. 2024 Jul 25;84(14):2618-2633.e10. doi: 10.1016/j.molcel.2024.06.031. Epub 2024 Jul 17.
3
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive.

本文引用的文献

1
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.三阴性乳腺癌化疗耐药的机制——我们如何应对挑战。
Cells. 2019 Aug 22;8(9):957. doi: 10.3390/cells8090957.
2
Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.靶向三阴性乳腺癌中的癌症干细胞
Cancers (Basel). 2019 Jul 9;11(7):965. doi: 10.3390/cancers11070965.
3
Advances in the systemic treatment of triple-negative breast cancer.三阴性乳腺癌全身治疗的进展
转移性三阴性乳腺癌的治疗策略:从阴性到阳性
Pharmaceuticals (Basel). 2021 May 12;14(5):455. doi: 10.3390/ph14050455.
4
The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies.Notch、Hedgehog和Wnt信号通路在肿瘤对抗癌治疗耐药性中的作用
Front Cell Dev Biol. 2021 Apr 22;9:650772. doi: 10.3389/fcell.2021.650772. eCollection 2021.
5
Stem Cells: Current Status and Therapeutic Implications.干细胞:现状与治疗意义。
Genes (Basel). 2020 Nov 20;11(11):1372. doi: 10.3390/genes11111372.
Curr Oncol. 2018 Jun;25(Suppl 1):S142-S150. doi: 10.3747/co.25.3954. Epub 2018 Jun 13.
4
Wnt Signaling in Stem Cells and Cancer Stem Cells: A Tale of Two Coactivators.Wnt 信号在干细胞和癌症干细胞中的作用:两个共激活因子的故事。
Prog Mol Biol Transl Sci. 2018 Jan;153:209-244. doi: 10.1016/bs.pmbts.2017.11.007. Epub 2017 Dec 21.
5
CD44/CD24 phenotype predicts a poor prognosis in triple-negative breast cancer.CD44/CD24表型预示三阴性乳腺癌预后不良。
Oncol Lett. 2017 Nov;14(5):5890-5898. doi: 10.3892/ol.2017.6959. Epub 2017 Sep 15.
6
Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells.Myc介导三阴性乳腺癌细胞中的癌干细胞样细胞及上皮-间质转化变化。
PLoS One. 2017 Aug 17;12(8):e0183578. doi: 10.1371/journal.pone.0183578. eCollection 2017.
7
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.上皮-间质转化、癌症干细胞与耐药性:机制联系及临床意义
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629. doi: 10.1038/nrclinonc.2017.44. Epub 2017 Apr 11.
8
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC).醛脱氢酶1(ALDH1)表达是三阴性乳腺癌(TNBC)的一个独立预后因素。
Medicine (Baltimore). 2017 Apr;96(14):e6561. doi: 10.1097/MD.0000000000006561.
9
Wnt signaling in triple-negative breast cancer.三阴性乳腺癌中的Wnt信号传导
Oncogenesis. 2017 Apr 3;6(4):e310. doi: 10.1038/oncsis.2017.14.
10
Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment.靶向癌症干细胞中的信号通路用于癌症治疗
Stem Cells Int. 2017;2017:2925869. doi: 10.1155/2017/2925869. Epub 2017 Mar 5.